Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000565459 | SCV000665018 | likely benign | Hereditary cancer-predisposing syndrome | 2016-09-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586053 | SCV000694627 | likely benign | not specified | 2019-08-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000920539 | SCV001065908 | likely benign | Hereditary breast ovarian cancer syndrome | 2024-11-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000565459 | SCV002051834 | likely benign | Hereditary cancer-predisposing syndrome | 2021-07-06 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000586053 | SCV002071280 | uncertain significance | not specified | 2019-10-09 | criteria provided, single submitter | clinical testing |